Dr Sarah Brüningk
The Institute of Cancer Research
Sarah completed a M.Sc. in Physics (Biophysics) at the Technische Universität München with the major focus on bio-medical and soft matter physics. Having worked in a medical physics group throughout her degree, she joined the clinical medical physics staff in the radiotherapy department at the Klinikum rechts der Isar in Munich until starting a PhD at the Institute of Cancer Research in October 2014. Her PhD focused on modelling and quantifying biological response to combination treatments of focused ultrasound mediated hyperthermia and radiotherapy. Since 2018 Sarah has been working as a Post Doctoral Training Fellow at the Institute of Cancer Research working on biology guided treatment planning for multimodality therapies.
The role of ultrasound therapy in cancer treatments
Therapeutic ultrasound is a non-invasive, localized technique to deliver heating and/or mechanical stress deep into tissue. Applications for cancer therapy range from pain palliation to disease eradication using a variety of techniques including hyperthermia, drug delivery enhancement, ablation (of tumour or nerves), and mechanical tissue disruption (histotripsy). It can be deployed either as single modality or in combination with other treatments, such as radiotherapy.
EVEN MORE SEMINARS
Dr Raj Jena Microsoft Research Cambridge & University of Cambridge Department of Oncology
Building AI workflows for segmentation and analysis of medical imaging
Professor Stuart Taylor University College London
Should we be using first line whole body MRI in colorectal and lung cancer staging?
Dr Heather E. L. Rose The University of Birmingham
MR imaging and Spectroscopy of Paediatric Brain Disease
Professor Jeff Bamber The Institute of Cancer Research and The Royal Marsden Hospital
Photoacoustic imaging in cancer medicine and research
Dr Rajesh Botchu Royal Orthopedic Hospital, Birmingham
MR imaging of bone tumours